Yamamoto M - Search Results

1

Significance of prostate/pancreatic/skin cancer family history for detecting BRCA2 pathogenic variant careers among patients with breast cancer.

Minoura Y, Takahashi M, Maeda H, Kuwahara S, Tachikawa H, Yamamoto M, Tomioka N, Watanabe K, Sakurai A. Minoura Y, et al. Among authors: yamamoto m. Breast Cancer. 2022 Sep;29(5):808-813. doi: 10.1007/s12282-022-01360-2. Epub 2022 May 31. Breast Cancer. 2022. PMID: 35641852

2

[Safety and tolerance of docetaxel (especially 75 mg/m2) with cyclophosphamide (TC therapy) as adjuvant chemotherapy for Japanese patients with operable breast cancer].

Watanabe K, Taguchi K, Yamamoto M, Jotoku H, Tamura M. Watanabe K, et al. Among authors: yamamoto m. Gan To Kagaku Ryoho. 2010 Jul;37(7):1265-9. Gan To Kagaku Ryoho. 2010. PMID: 20647707 Japanese.

3

Prognostic significance of pathologic complete response and Ki67 expression after neoadjuvant chemotherapy in breast cancer.

Yoshioka T, Hosoda M, Yamamoto M, Taguchi K, Hatanaka KC, Takakuwa E, Hatanaka Y, Matsuno Y, Yamashita H. Yoshioka T, et al. Among authors: yamamoto m. Breast Cancer. 2015 Mar;22(2):185-91. doi: 10.1007/s12282-013-0474-2. Epub 2013 May 5. Breast Cancer. 2015. PMID: 23645542 Free article. Clinical Trial.

4

Fulvestrant 500 mg in postmenopausal patients with metastatic breast cancer: the initial clinical experience.

Ishida N, Araki K, Sakai T, Kobayashi K, Kobayashi T, Fukada I, Hosoda M, Yamamoto M, Ichinokawa K, Takahashi S, Iwase T, Ito Y, Yamashita H. Ishida N, et al. Among authors: yamamoto m. Breast Cancer. 2016 Jul;23(4):617-23. doi: 10.1007/s12282-015-0612-0. Epub 2015 Apr 21. Breast Cancer. 2016. PMID: 25896598 Free article. Clinical Trial.

5

[Safety and Tolerance of Dose-Dense Epirubicin and Cyclophosphamide (EC) with Pegfilgrastim for Japanese Patients with Early Breast Cancer].

Watanabe K, Sato M, Yamamoto M, Ikarashi M, Hagio K, Tomioka N, Tamaki S, Takahashi Y, Takahasi M. Watanabe K, et al. Among authors: yamamoto m. Gan To Kagaku Ryoho. 2016 Apr;43(4):435-8. Gan To Kagaku Ryoho. 2016. PMID: 27220788 Japanese.

6

The therapeutic candidate for immune checkpoint inhibitors elucidated by the status of tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) expression in triple negative breast cancer (TNBC).

Tomioka N, Azuma M, Ikarashi M, Yamamoto M, Sato M, Watanabe KI, Yamashiro K, Takahashi M. Tomioka N, et al. Among authors: yamamoto m. Breast Cancer. 2018 Jan;25(1):34-42. doi: 10.1007/s12282-017-0781-0. Epub 2017 May 9. Breast Cancer. 2018. PMID: 28488168

7

Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region.

Tomioka N, Hatanaka KC, Okuyama D, Watanabe KI, Yamamoto M, Maeda H, Tachikawa H, Kuwahara S, Shimizu A, Suzuki H, Hatanaka Y, Takahashi M. Tomioka N, et al. Among authors: yamamoto m. Breast Cancer. 2023 May;30(3):497-505. doi: 10.1007/s12282-023-01442-9. Epub 2023 Mar 9. Breast Cancer. 2023. PMID: 36892732 Free PMC article.

8

Correction: Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region.

Tomioka N, Hatanaka KC, Okuyama D, Watanabe KI, Yamamoto M, Maeda H, Tachikawa H, Kuwahara S, Shimizu A, Suzuki H, Hatanaka Y, Takahashi M. Tomioka N, et al. Among authors: yamamoto m. Breast Cancer. 2023 Jul;30(4):689-690. doi: 10.1007/s12282-023-01454-5. Breast Cancer. 2023. PMID: 37103743 Free PMC article. No abstract available.

9

Clinical Management of Potential Toxicity of Abemaciclib and Approaches to Ensure Treatment Continuation.

Takada S, Maeda H, Umehara K, Kuwahara S, Yamamoto M, Tomioka N, Takahashi M, Watanabe K, Hashishita H. Takada S, et al. Among authors: yamamoto m. Asian Pac J Cancer Prev. 2023 Jun 1;24(6):1955-1962. doi: 10.31557/APJCP.2023.24.6.1955. Asian Pac J Cancer Prev. 2023. PMID: 37378924 Free PMC article.

10

Real-World Predictors of Severe Neutropenia Associated with Palbociclib and Endocrine Therapy for Metastatic Breast Cancer in Japanese Patients.

Takada S, Maeda H, Umehara K, Kuwahara S, Yamamoto M, Tomioka N, Watanabe K, Mino K. Takada S, et al. Among authors: yamamoto m. Biol Pharm Bull. 2023;46(8):1105-1111. doi: 10.1248/bpb.b23-00187. Biol Pharm Bull. 2023. PMID: 37532561 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,367 results

Search Page

Filters